Investigation on Safety, Tolerability and Bioavailability of Oral Semaglutide in Healthy Male Subjects.

Trial Profile

Investigation on Safety, Tolerability and Bioavailability of Oral Semaglutide in Healthy Male Subjects.

Completed
Phase of Trial: Phase I

Latest Information Update: 02 Mar 2017

At a glance

  • Drugs Semaglutide (Primary) ; Semaglutide (Primary) ; Semaglutide (Primary)
  • Indications Type 2 diabetes mellitus
  • Focus Adverse reactions
  • Sponsors Novo Nordisk
  • Most Recent Events

    • 15 May 2010 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
    • 15 May 2010 Actual end date (May 2010) added as reported by ClinicalTrials.gov.
    • 14 Jan 2010 Results of this trial are expected in 2011, according to a Novo Nordisk media release.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top